C116H136F2N14O8S4 — CID 159501591
(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(6-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(7-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2R)-N-[(2S)-3,3-dimethyl-1-oxo-1-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]-2-methylbutanamide;(2R)-2-methyl-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]butanamide (PubChem CID 159501591) has the molecular formula C116H136F2N14O8S4 and a molecular weight of 2020.72 g/mol. Its IUPAC name is (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(6-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(7-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2R)-N-[(2S)-3,3-dimethyl-1-oxo-1-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]-2-methylbutanamide;(2R)-2-methyl-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]butanamide.
| Compound Name | (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(6-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(7-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2R)-N-[(2S)-3,3-dimethyl-1-oxo-1-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]-2-methylbutanamide;(2R)-2-methyl-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]butanamide |
|---|---|
| PubChem CID | 159501591 |
| Molecular Formula | C116H136F2N14O8S4 |
| Molecular Weight | 2020.72 g/mol |
| Exact Mass | 2018.95 |
| IUPAC Name | (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(6-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(7-fluoro-4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide;(2R)-N-[(2S)-3,3-dimethyl-1-oxo-1-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]-2-methylbutanamide;(2R)-2-methyl-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]butanamide |
| SMILES | CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)cccc2s1)C(C)(C)C.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)cccc2s1)c1ccccc1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)cc(F)cc2s1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)ccc(F)c2s1)C1CCCCC1 |
| InChI | InChI=1S/C30H31N3O2S.2C29H35FN4O2S.C28H35N3O2S/c1-3-20(2)28(34)31-26(22-14-8-5-9-15-22)30(35)33-19-11-17-24(33)29-32-27-23(16-10-18-25(27)36-29)21-12-6-4-7-13-21;1-18(31-2)27(35)32-24(20-12-7-4-8-13-20)29(36)34-17-9-14-23(34)28-33-25-21(19-10-5-3-6-11-19)15-16-22(30)26(25)37-28;1-18(31-2)27(35)32-25(20-12-7-4-8-13-20)29(36)34-15-9-14-23(34)28-33-26-22(19-10-5-3-6-11-19)16-21(30)17-24(26)37-28;1-6-18(2)25(32)30-24(28(3,4)5)27(33)31-17-11-15-21(31)26-29-23-20(14-10-16-22(23)34-26)19-12-8-7-9-13-19/h4-10,12-16,18,20,24,26H,3,11,17,19H2,1-2H3,(H,31,34);3,5-6,10-11,15-16,18,20,23-24,31H,4,7-9,12-14,17H2,1-2H3,(H,32,35);3,5-6,10-11,16-18,20,23,25,31H,4,7-9,12-15H2,1-2H3,(H,32,35);7-10,12-14,16,18,21,24H,6,11,15,17H2,1-5H3,(H,30,32)/t20-,24+,26+;18-,23-,24-;18-,23-,25-;18-,21+,24-/m1001/s1 |
| InChIKey | LZLJPVLSNRBQNX-YXXGFFRRSA-N |
| XLogP | 23.61 |
| TPSA | 273.26 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 144 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2020.72 |
| LogP ≤ 5 | 23.61 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 18 |